Hemp Seed Awareness
Hemp is a plant of the Cannabaceae family. Cannabis sativa, derived from female flowers, is the first illicit substance used by adolescents and is a major public health problem. Its psycho-active effects come from tetrahydrocannabinol (THC). Unlike recreational cannabis, industrial hemp derived from cannabis sativa has
| Condition(s) | Allergy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Hemp is a plant of the Cannabaceae family. Cannabis sativa, derived from female flowers, is the first illicit substance used by adolescents and is a major public health problem. Its psycho-active effects come from tetrahydrocannabinol (THC). Unlike recreational cannabis, industrial hemp derived from cannabis sativa has a high level of cannabidiol (CBD) but a negligible level of tetrahydrocannabinol. Its seeds are now consumed in various forms and generate increasing interest. Seeds have many nutritional benefits. It seems important to take an interest in hemp, given the recent expansion of medical cannabis and the increasing use of cannabis for recreational purposes. It is incriminated in various allergies (contact dermatitis, asthma, rhinoconjunctivitis) but also in the occurrence of anap |
| Who can participate | Inclusion Criteria: * Major patient * Patient referred to the Allergology Unit of the Hospital of Angers, in consultation or in Hospitalization - for conducting prick-tests * Patient affiliated or beneficiary of a social security scheme * Patient with informed consent Exclusion Criteria: * Pregnant women, parturients * Persons deprived of liberty by administrative or judicial decision * Persons receiving psychiatric care under duress * Adults under legal protection measure * People out of state to express consent * people not able to understand French language * Patients whose skin reactivity prevents interpretation of tests (patients who cannot interrupt anti-histamines or have severe eczema) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University Hospital, Angers |
| Locations | Angers, France |
| Start date | 2021-06-01 |
| NCT ID | NCT04841954 |
| Official listing | https://clinicaltrials.gov/study/NCT04841954 |